RA
Rosalind Advisors, Inc.
趋势追踪型分散型投资策略高品质投资策略
申报总市值
US$2.5亿
申报季度: 2026-03-31 · 持股只数: 38
Rosalind Advisors, Inc.在最新一期 13F 报告中披露了 38 项持股，申报期为 2026-03-31，总持股市值约为 US$2.5亿，季度换手率为 69.1%。
机构性格雪花图
- 集中度
- 22.34
- 持仓稳定性
- 69.06
- 动能／逆势
- 100
- 行业集中度
- 0
- 多样化
- 76
- 仓位均衡度
- 89.26
近期动向
减仓 VRDN
-44.4% -US$910.6万
减仓 HELP
-7.6% -US$620.6万
加仓 XERS
+53.0% US$216.7万
加仓 XFOR
+23.4% US$285.3万
减仓 CGON
-66.7% -US$568.8万
加仓 76029N906
+452.4% US$273.5万
持仓地图
新建仓加仓不变减仓
前十大持股占比
本季完整持股清单
| # | 代码 | 标的名称 | 资产子类别 | 占比 | 占比变动 | 持仓量变化 | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | DCTH | Delcath Systems INC | 股票-其他 | 12.31% | +0.71% | — | |
| 2 | XERS | Xeris Biopharma Holdings INC | 股票-其他 | 7.53% | +1.70% | +53.04% | |
| 3 | FENC | Fennec Pharmaceuticals INC | 股票-其他 | 7.19% | +0.12% | +11.28% | |
| 4 | SVRA | Savara INC | 股票-其他 | 7.03% | -0.18% | -5.88% | |
| 5 | PCVX | Vaxcyte INC | 股票-其他 | 6.77% | +6.77% | NEW | |
| 6 | EYPT | Eyepoint INC | 股票-其他 | 5.37% | +0.94% | +50.25% | |
| 7 | XFOR | X4 Pharmaceuticals INC | 股票-其他 | 5.33% | +1.67% | +23.36% | |
| 8 | VOR | Vor Biopharma INC | 股票-其他 | 5.02% | +5.02% | NEW | |
| 9 | ✓ | Mediwound LTD | 股票-其他 | 4.85% | -0.01% | — | |
| 10 | VSTM | Verastem INC | 股票-其他 | 4.55% | -0.30% | +19.57% | |
| 11 | CLDX | Celldex Therapeutics INC | 股票-其他 | 4.21% | +4.21% | NEW | |
| 12 | BCRX | Biocryst Pharmaceuticals INC | 股票-其他 | 3.53% | +3.53% | NEW | |
| 13 | HELP | Cybin INC | 股票-其他 | 2.95% | -1.82% | -7.59% | |
| 14 | CGON | Cg Oncology INC | 股票-其他 | 2.72% | -1.66% | -66.67% | |
| 15 | NSPR | Inspiremd INC | 股票-其他 | 2.56% | +0.12% | — | |
| 16 | AVIR | Atea Pharmaceuticals INC | 股票-其他 | 2.53% | +2.53% | NEW | |
| 17 | PROF | Profound Medical CORP | 股票-其他 | 2.16% | -0.80% | -22.53% | |
| 18 | VRDN | Viridian Therapeutics INC | 股票-其他 | 1.97% | -2.95% | -44.36% | |
| 19 | ✓ | Replimune Group INC | 股票-其他 | 1.10% | +1.10% | +452.45% | |
| 20 | ✓ | Polypid LTD | 股票-其他 | 1.05% | -0.01% | -14.16% | |
| 21 | MYO | Myomo INC | 股票-其他 | 1.04% | -0.19% | +0.20% | |
| 22 | TLPH | Talphera INC | 股票-其他 | 1.01% | -0.42% | -6.30% | |
| 23 | OVID | Ovid Therapeutics INC | 股票-其他 | 0.99% | +0.99% | NEW | |
| 24 | DFTX | Definium Therapeutics INC | 股票-其他 | 0.95% | +0.95% | NEW | |
| 25 | OKUR | Onkure Therapeutics Inc-a | 股票-其他 | 0.74% | — | -39.25% | |
| 26 | LPCN | Lipocine INC | 股票-其他 | 0.71% | +0.71% | NEW | |
| 27 | NRXS | Neuraxis INC | 股票-其他 | 0.68% | +0.31% | — | |
| 28 | AVTX | Avalo Therapeutics INC | 股票-其他 | 0.45% | +0.45% | NEW | |
| 29 | ANNX | Annexon INC | 股票-其他 | 0.45% | +0.45% | NEW | |
| 30 | ✓ | 股票-其他 | 0.42% | -0.64% | -44.44% | ||
| 31 | AQST | Aquestive Therapeutics INC | 股票-其他 | 0.42% | +0.42% | NEW | |
| 32 | ✓ | Spdr S&p 500 ETF Tr | ETF-大型股与成长 | 0.39% | -0.27% | -75.49% | |
| 33 | BFRI | Biofrontera INC | 股票-其他 | 0.38% | +0.15% | +2.03% | |
| 34 | KURA | Kura Oncology INC | 股票-其他 | 0.33% | -0.04% | — | |
| 35 | ✓ | Regentis Biomaterials LTD | 股票-其他 | 0.31% | -0.29% | — | |
| 36 | ✓ | Viridian Therapeutics INC | 股票-其他 | 0.02% | +0.02% | NEW | |
| 37 | ✓ | Arrivent Biopharma INC | 股票-其他 | — | -0.19% | +0.93% | |
| 38 | ✓ | Uniqure NV | 股票-其他 | — | -0.03% | +195.80% |
申报总市值趋势
行业配置
暂无足够的行业对照数据
历年行业分布趋势
季度历史总览
| 季度 | 持股只数 | 总市值 | 稳定性 | 主要持股 |
|---|---|---|---|---|
| 2026-03-31 | 38 | US$2.5亿 | 69 | |
| 2025-12-31 | 42 | US$2.8亿 | 49 | |
| 2025-09-30 | 39 | US$2.9亿 | 87 | |
| 2025-06-30 | 37 | US$2.1亿 | 0 | |
| 2025-03-31 | 34 | US$2.1亿 | 0 | |
| 2024-12-31 | 40 | US$2.0亿 | 0 | |
| 2024-09-30 | 33 | US$1.6亿 | 0 | |
| 2024-06-30 | 40 | US$1.3亿 | 0 | |
| 2024-03-31 | 34 | US$1.1亿 | 0 | |
| 2023-12-31 | 30 | US$1.2亿 | 0 |
本季持股变动
Rosalind Advisors, Inc. 在 2026-03-31 最显著的持仓异动： 新建仓: Vaxcyte INC (PCVX); 清仓: Replimune Group INC (REPL); 清仓: Atyr Pharma INC (ATYR); 新建仓: Vor Biopharma INC (VOR); 清仓: Cytokinetics INC (CYTK).
| # | 代码 | 标的名称 | 占比变动 | 持仓量变化 | 异动类型 |
|---|---|---|---|---|---|
| 1 | XERS | Xeris Biopharma Holdings INC | +1.7% | +53.04% | 加仓 |
| 2 | XFOR | X4 Pharmaceuticals INC | +1.7% | +23.36% | 加仓 |
| 3 | ✓ | Replimune Group INC | +1.1% | +452.45% | 加仓 |
| 4 | EYPT | Eyepoint INC | +0.9% | +50.25% | 加仓 |
| 5 | DCTH | Delcath Systems INC | +0.7% | — | 不变 |
| 6 | NRXS | Neuraxis INC | +0.3% | — | 不变 |
| 7 | BFRI | Biofrontera INC | +0.2% | +2.03% | 加仓 |
| 8 | FENC | Fennec Pharmaceuticals INC | +0.1% | +11.28% | 加仓 |
| 9 | NSPR | Inspiremd INC | +0.1% | — | 不变 |
| 10 | OKUR | Onkure Therapeutics Inc-a | — | -39.25% | 减仓 |
| 11 | ✓ | Mediwound LTD | 0% | — | 不变 |
| 12 | ✓ | Polypid LTD | 0% | -14.16% | 减仓 |
| 13 | ✓ | Uniqure NV | 0% | +195.80% | 加仓 |
| 14 | KURA | Kura Oncology INC | 0% | — | 不变 |
| 15 | SVRA | Savara INC | -0.2% | -5.88% | 减仓 |
| 16 | MYO | Myomo INC | -0.2% | +0.20% | 加仓 |
| 17 | ✓ | Arrivent Biopharma INC | -0.2% | +0.93% | 加仓 |
| 18 | ✓ | Spdr S&p 500 ETF Tr | -0.3% | -75.49% | 减仓 |
| 19 | ✓ | Regentis Biomaterials LTD | -0.3% | — | 不变 |
| 20 | VSTM | Verastem INC | -0.3% | +19.57% | 加仓 |
| 21 | TLPH | Talphera INC | -0.4% | -6.30% | 减仓 |
| 22 | ✓ | -0.6% | -44.44% | 减仓 | |
| 23 | PROF | Profound Medical CORP | -0.8% | -22.53% | 减仓 |
| 24 | CGON | Cg Oncology INC | -1.7% | -66.67% | 减仓 |
| 25 | HELP | Cybin INC | -1.8% | -7.59% | 减仓 |
| 26 | VRDN | Viridian Therapeutics INC | -3% | -44.36% | 减仓 |
| 27 | PCVX | Vaxcyte INC | — | NEW | 新建仓 |
| 28 | REPL | Replimune Group INC | — | EXIT | 清仓 |
| 29 | ATYR | Atyr Pharma INC | — | EXIT | 清仓 |
| 30 | VOR | Vor Biopharma INC | — | NEW | 新建仓 |
| 31 | CYTK | Cytokinetics INC | — | EXIT | 清仓 |
| 32 | CLDX | Celldex Therapeutics INC | — | NEW | 新建仓 |
| 33 | BRD1EUR | Mind Medicine Mindmed INC | — | EXIT | 清仓 |
| 34 | BCRX | Biocryst Pharmaceuticals INC | — | NEW | 新建仓 |
| 35 | AVIR | Atea Pharmaceuticals INC | — | NEW | 新建仓 |
| 36 | OCUL | Ocular Therapeutix INC | — | EXIT | 清仓 |
| 37 | AVBP | Arrivent Biopharma INC | — | EXIT | 清仓 |
| 38 | OVID | Ovid Therapeutics INC | — | NEW | 新建仓 |
| 39 | DFTX | Definium Therapeutics INC | — | NEW | 新建仓 |
| 40 | ✓ | Anavex Life Sciences CORP | — | EXIT | 清仓 |
| 41 | LPCN | Lipocine INC | — | NEW | 新建仓 |
| 42 | ✓ | Spdr Series Trust | — | EXIT | 清仓 |
| 43 | TRVI | Trevi Therapeutics INC | — | EXIT | 清仓 |
| 44 | AVTX | Avalo Therapeutics INC | — | NEW | 新建仓 |
| 45 | ✓ | Ishares Tr | — | EXIT | 清仓 |
| 46 | ANNX | Annexon INC | — | NEW | 新建仓 |
| 47 | AQST | Aquestive Therapeutics INC | — | NEW | 新建仓 |
| 48 | GUTS | Fractyl Health INC | — | EXIT | 清仓 |
| 49 | ✓ | Verastem INC | — | EXIT | 清仓 |
| 50 | ✓ | Viridian Therapeutics INC | — | NEW | 新建仓 |
FAQ
Rosalind Advisors, Inc. 是什么机构？属于哪种投资人类型？
Rosalind Advisors, Inc. 是一家投资管理机构，每季依规定向 SEC 申报 Form 13F，披露其在美国上市股票的持仓信息。根据最新一期申报（2026-03-31），该机构追踪的股票投资组合估值约为 US$2.5亿，分布在 38 个已申报仓位之中。
Rosalind Advisors, Inc. 目前前几大持股有哪些？
根据最新 13F 申报，Rosalind Advisors, Inc. 按市值排列的前几大持股为：
1. Delcath Systems INC (DCTH) — US$3062.8万 (12.3%)
2. Xeris Biopharma Holdings INC (XERS) — US$1874.4万 (7.5%)
3. Fennec Pharmaceuticals INC (FENC) — US$1788.5万 (7.2%)
4. Savara INC (SVRA) — US$1749.2万 (7.0%)
5. Vaxcyte INC (PCVX) — US$1685.2万 (6.8%)
Rosalind Advisors, Inc. 在最新一期 13F 申报中做了哪些操作？
在最新申报季度中，Rosalind Advisors, Inc. 共进行了 44 项显著调整：新建仓 12 个仓位、加仓 10 个既有持股、减仓 10 个仓位，并完全清仓 12 个持股。 其中幅度最大的异动：新建仓: Vaxcyte INC (PCVX); 清仓: Replimune Group INC (REPL); 清仓: Atyr Pharma INC (ATYR); 新建仓: Vor Biopharma INC (VOR); 清仓: Cytokinetics INC (CYTK)
Rosalind Advisors, Inc. 主要集中投资哪些行业板块？
目前暂无 Rosalind Advisors, Inc. 的板块分布数据，请在下次 13F 处理周期后再次查看。